Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 1 results out of 1
Data Insights
LOAd-703 by Lokon Pharma for Metastatic Biliary Tract Cancer: Likelihood of Approval
LOAd-703 is under clinical development by Lokon Pharma and currently in Phase II for Metastatic Biliary Tract Cancer. According to...